Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Fabienne Vacheret"'
Autor:
Nadia Younan, Carole Soussain, Sylvain Choquet, Nathalie Cassoux, Valérie Touitou, Anna Schmitt, Olivier Chinot, Lucie Oberic, Gandhi Damaj, Roch Houot, Hervé Ghesquières, Kamel Laribi, Guido Ahle, Luc Taillandier, Jérôme Paillassa, Emmanuel Gyan, Fabrice Jardin, Vincent Delwail, Jean‐Pierre Marolleau, Adrian Tempescul, Philippe Agapé, Marie Bourniquel, Fabienne Vacheret, Ibrahim Jdid, Magali Le Garff‐Tavernier, Denis Malaise, Agusti Alentorn, Khê Hoang Xuan, Caroline Houillier
Publikováno v:
Hematological Oncology
Hematological Oncology, 2022, 40 (5), pp.976-986. ⟨10.1002/hon.3044⟩
Hematological Oncology, 2022, 40 (5), pp.976-986. ⟨10.1002/hon.3044⟩
Most relapses of primary central nervous system lymphoma (PCNSL) occur in the brain and are associated with a poor prognosis. Isolated intraocular relapses (IIORs) are rare and poorly described. We retrospectively selected from the French Lymphome Oc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aecaed90c3b3273887ae266d432b2a5e
https://hal-u-picardie.archives-ouvertes.fr/hal-03716518/document
https://hal-u-picardie.archives-ouvertes.fr/hal-03716518/document
Autor:
Jean-Claude Chomel, Jean-Christophe Ianotto, Laurane Cottin, Pierre Sujobert, Véronique Mansat-De Mas, Barbara Burroni, Vincent Cussac, Nathalie Jézéquel, Brigitte Dupriez, Bruno Cassinat, Emmanuelle Verger, Raouf Ben Abdelali, Dana Ranta, Damien Luque Paz, Olivier Kosmider, Olivier Mansier, Gabriel Etienne, Jerome Rey, Maxime Renard, Jean-Jacques Kiladjian, Fabienne Vacheret, Guillaume Denis, Anne Murati, Jérémie Riou, Pascal Mossuz, Françoise Boyer, Eric Lippert, Yannick Le Bris, Pascale Cony-Makhoul, Ivan Sloma, Anouk Walter-Petrich, Suzanne Tavitian, Stéphane Giraudier, Stéphane Girault, Aurélie Chauveau, Gérard Socié, François Girodon, Lydia Roy, Olivier Nibourel, Borhane Slama, Valérie Ugo, Margot Robles, Mathieu Wemeau
Publikováno v:
Blood Advances
Blood Advances, 2021, 5, pp.1442-1451. ⟨10.1182/bloodadvances.2020003444⟩
Blood Advances, The American Society of Hematology, 2021, 5, pp.1442-1451. ⟨10.1182/bloodadvances.2020003444⟩
Blood Adv
Blood Advances, 2021, 5, pp.1442-1451. ⟨10.1182/bloodadvances.2020003444⟩
Blood Advances, The American Society of Hematology, 2021, 5, pp.1442-1451. ⟨10.1182/bloodadvances.2020003444⟩
Blood Adv
We aimed to study the prognostic impact of the mutational landscape in primary and secondary myelofibrosis. The study included 479 patients with myelofibrosis recruited from 24 French Intergroup of Myeloproliferative Neoplasms (FIM) centers. The mole
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c8940c1350fb349d712d80d7c3b70f5
https://www.hal.inserm.fr/inserm-03187575/document
https://www.hal.inserm.fr/inserm-03187575/document
Autor:
Jean-Luc Faillie, Pauline Sauguet, Fabienne Vacheret, Sara Burcheri, Dominique Hillaire-Buys, Christine Biron-Andreani, Jean-François Schved, Alexandre Theron
Publikováno v:
Thrombosis Research
Thrombosis Research, Elsevier, 2017, 157, pp.154-156. ⟨10.1016/j.thromres.2017.06.007⟩
Thrombosis Research, Elsevier, 2017, 157, pp.154-156. ⟨10.1016/j.thromres.2017.06.007⟩
International audience
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2d1412496c8c4fd8923be09aee9aa27
https://doi.org/10.1016/j.thromres.2017.06.007
https://doi.org/10.1016/j.thromres.2017.06.007
Autor:
Eric Jourdan, Jean Chiesa, Florence Ruffle, David Piquemal, Anthony Boureux, Elias Bou Samra, Ken I. Mills, Thierry Lavabre-Bertrand, Thérèse Commes, Jérôme Moreaux, Fabienne Vacheret
Publikováno v:
British Journal of Haematology. 157:347-356
Summary Chronic myelomonocytic leukaemia (CMML) is a heterogeneous haematopoietic disorder characterized by myeloproliferative or myelodysplastic features. At present, the pathogenesis of this malignancy is not completely understood. In this study, w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53ce0daadea285f32b4d9a214429fe10
https://doi.org/10.1111/j.1365-2141.2012.09069.x
https://doi.org/10.1111/j.1365-2141.2012.09069.x
Autor:
Ahmad Al Jijakli, Sophie Dupire, Jerome Rey, Ronan Le Calloch, Françoise Boyer, Suzanne Tavitian, Brigitte Dupriez, Philippe Rodon, Stéphane Courby, Valérie Ugo, Fiorenza Barraco, Jean-Loup Demory, Anne Vekhoff, Jean-Christophe Ianotto, Pierre Morel, Mathieu Wemeau, Lise Willems, Nathalie Cambier, François Girodon, Isabelle Plantier, Gabriel Etienne, Jean-Jacques Kiladjian, Bohrane Slama, Kamel Laribi, Sandra Malak, Sylvie Chevret, Stéphane Giraudier, Laurence Legros, Marc A. Simon, Fabienne Vacheret, Eric Lippert, Dana Ranta, Selim Corm, Pascale Cony-Makhoul, Laurent Knoops
Publikováno v:
Blood. 128:3128-3128
Background: Myelofibrosis (MF) is the less frequent Philadelphia-negative myeloproliferative neoplasms (MPN). We have included in a nationwide database primary (P), post-polycythemia (PPV) and post-essential thrombocythemia (PET) MF diagnosed in Fran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5c582d3a2249c9c3ca75b7625d06eb5b
https://doi.org/10.1182/blood.v128.22.3128.3128
https://doi.org/10.1182/blood.v128.22.3128.3128